Byoung Soo Cho

Byoung Soo Cho

Auto-generated profile, based on publicly available information

Byoung Soo Cho

Dr. Cho’s Kidney Clinic, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2009 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
BCByoung Soo Cho
Byoung Soo Cho
JSJin Soon Suh
Jin Soon Suh
WHWon Ho Hahn
Won Ho Hahn
SKSung Do Kim
Sung Do Kim
JLJoo Won Lim
Joo Won Lim

1 January 1999 in Korean Journal of Pediatric Infectious Diseases
Verified
Journal Article
Closed access
SLSung Soo Lee
Sung Soo Lee
KYKyung Lim Youn
Kyung Lim Youn
HKHyeon Ho Kang
Hyeon Ho Kang
BCByoung Soo Cho
Byoung Soo Cho
SCSung Ho Cha
Sung Ho Cha

28 October 2024 in Childhood Kidney Diseases
Verified
Journal Article
Open access
PDF file
HKHae Min Kim
Hae Min Kim
Jae Il ShinJae Il Shin
Jae Il Shin
지김지홍 김
지홍 김
JOJiyoung Oh
Jiyoung Oh
JKJi-Man Kang
Ji-Man Kang
KLKeum Hwa Lee
Keum Hwa Lee
Complement component 3 glomerulonephritis (C3GN) is a rare kidney disease characterized by complement dysregulation that results in prominent complement component 3 (C3) deposition in the kidneys. The clinical course of C3GN varies from mild hematuria to progressive chronic kidney disease. In most patients, C3GN is driven by acquired factors, namely, autoantibodies that target C3 or C5 convertases. Genetic variations in complement-related genes are less frequent. We report the case of a 9-yearold Korean boy who presented with microscopic hematuria and a persistently low C3 level and had biopsy findings of C3GN, with the presence of a C3 gene mutation: a frameshift mutation associated with C3 deficiency. However, the patient did not exhibit any other symptoms of complement deficiency. Direct DNA sequencing of his family members revealed the same genetic mutation in his father and older brother. This case report is significant because there are very few such reports worldwide concerning gene mutations related to C3 deficiency to be discovered in patients with C3GN. Explaining C3GN pathogenesis is challenging; therefore, additional research is required in the future.